전체 프로그램

ADC 882 · Antibody 4071 · CGT 2714 · 자동 수집 갱신 권장 · 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved119 programs

데이터 갱신 주기입니다. 갱신 대기 7,666개 보기 · Curated Core는 주간 자동 동기화됩니다.

CGTLimited DatastaleMustang BioPreclinical

Prior MB-102 CAR-T cell investigational product. (Prior MB-102 CAR-T cell investigational product.)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Chronic Lymphocytic Leukemia in Relapse · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
CGTLimited DatastaleMustang BioPreclinical

Prior MB-106 CAR-T cell investigational product. (Prior MB-106 CAR-T cell investigational product.)

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN); Chronic Lymphocytic Leukemia in Relapse · FRα

#FR#CGT#Preclinical#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
AntibodyLimited DatastaleHoffmann-La RochePhase 1

atezolizumab (Tecentriq, RO7567132 and Atezolizumab)

Cancer-Neoplasms · Cancer-Neoplasms

#Cancer-Neoplasms#Antibody#Phase1#monoclonal-antibody#Hoffmann-La
Trials 1Status Recruiting
CGTLimited DatastaleFred Hutchinson Cancer CenterPhase 1

ROR1 CAR-specific Autologous T-Lymphocytes (ROR1 CAR-specific Autologous T-Lymphocytes)

Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm · FRα

#FR#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Discontinued
AntibodyLimited DatastaleZhejiang Cancer HospitalPhase 2

Recombinant human adenovirus type 5＋Camrelizumab (Recombinant human adenovirus type 5＋Camrelizumab)

Uterine Cervical Neoplasms; Oncolytic Virotherapy · Uterine Cervical Neoplasms

#UterineCervicalNeoplasms#Antibody#Phase2#monoclonal-antibody#OncolyticVirotherapy+1
Trials 1Status Active
AntibodyLimited DatastaleRochePreclinical

proposed trastuzumab biosimilar (SB3, SB3 (proposed trastuzumab biosimilar))

Breast Neoplasms · HER2

#HER2#Antibody#Preclinical#monoclonal-antibody#BreastNeoplasms+1
Trials 1Status Discontinued
CGTLimited DatastalesuhaichuanPreclinical

TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy (TM4SF1- and EpCAM-positive chimeric antigen receptor T-cell therapy)

Advanced Solid Tumor; Neoplasms · Advanced Solid Tumor

#AdvancedSolidTumor#CGT#Preclinical#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleRochePhase 3

trastuzumab (TX05, TX05 (trastuzumab))

Breast Cancer; Breast Neoplasms · HER2

#HER2#Antibody#Phase3#monoclonal-antibody#BreastCancer+2
Trials 1Status Active
AntibodyLimited DatastaleJunshi BiosciencesPhase 3

JS001 (Toripalimab, Toripalimab (JS001 ))

Urinary Bladder Neoplasms · Urinary Bladder Neoplasms

#UrinaryBladderNeoplasms#Antibody#Phase3#monoclonal-antibody#Junshi
Trials 1Status Recruiting
AntibodyLimited DatastaleQuantumLeap Healthcare Collabor…Phase 2

trastuzumab (Herceptin, Trilaciclib with or without trastuzumab + pertuzumab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Recruiting
CGTLimited DatastaleIntima Bioscience, Inc.Phase 2

TIL (Tumor-Infiltrating Lymphocytes, Tumor-Infiltrating Lymphocytes (TIL))

Gastrointestinal Epithelial Cancer; Gastrointestinal Neoplasms · Gastrointestinal Epithelial Cancer

#GastrointestinalEpithelialCancer#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active
AntibodyLimited DatastaleClinica Universidad de Navarra,…Phase 2

nivolumab (Opdivo, Urelumab + Nivolumab)

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase2#monoclonal-antibody#Clinica
Trials 1Status Active
AntibodyLimited DatastaleJules Bordet InstitutePhase 1

trastuzumab (Herceptin, Zr89-trastuzumab)

Breast Neoplasms; Secondary · HER2

#HER2#Antibody#Phase1#monoclonal-antibody#BreastNeoplasms+2
Trials 1Status Active
AntibodyLimited DatastaleGlaxoSmithKlinePhase 1

GSK3359609 (feladilimab, feladilimab (GSK3359609))

Neoplasms · Neoplasms

#Neoplasms#Antibody#Phase1#monoclonal-antibody#GlaxoSmithKline
Trials 1Status Active
CGTLimited DatastaleInnovative Cellular Therapeutic…Preclinical

gucy2c cart cells (gucy2c cart cells)

Malignant Neoplasms of Digestive Organs · Malignant Neoplasms of Digestive Organs

#MalignantNeoplasmsofDigestiveOrg#CGT#Preclinical#cell-gene-therapy#CAR-T+2
Trials 1Status Active
CGTLimited DatastaleUNC Lineberger Comprehensive Ca…Phase 1

iC9-CAR.B7-H3 T cells (iC9-CAR.B7-H3 T cells)

Ovary Neoplasm; Ovarian Cancer · B7-H3

#B7-H3#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 1

mCD19-CAR-CD28-CD3-zeta. (anti-CD19 CAR, mCD19-CAR-CD28-CD3-zeta., mCD19-CAR-CD28-CD3-zeta.(anti-CD19 CAR) retroviral vector-transduced allogeneic peripheral blood lymphocytes (PBL))

Hematologic Malignancies; Hematologic Neoplasms · CD19

#CD19#CGT#Phase1#cell-gene-therapy#CAR-T+4
Trials 1Status Recruiting
AntibodyLimited DatastaleRochePhase 3

miFL + bevacizumab (miFL + bevacizumab)

Colorectal Neoplasms · Colorectal Neoplasms

#ColorectalNeoplasms#Antibody#Phase3#monoclonal-antibody#Roche
Trials 1Status Active
CGTLimited DatastaleNational Cancer Institute (NCI)Phase 2

peripheral blood progenitor cells carrying MDR1 (peripheral blood progenitor cells carrying MDR1)

Breast Neoplasms; Neoplasm Metastasis · Breast Neoplasms

#BreastNeoplasms#CGT#Phase2#cell-gene-therapy#CAR-T+3
Trials 1Status Active

6 / 6 pages

← PreviousNext →